Stock MOC MOLECURE S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Molecure S.A.

Equities

MOC

PLONCTH00011

Market Closed - Warsaw S.E.
Other stock markets
 11:55:41 2024-07-11 am EDT 		5-day change 1st Jan Change
13.78 PLN -0.14% Intraday chart for Molecure S.A. +3.61% -29.33%
May. 21 Molecure S.A. Receives Approval to Initiate A Phase II Clinical Trial for OATD-01 for the Treatment of Pulmonary Sarcoidosis in Selected Countries of the European Union and Norway CI
May. 17 Molecure S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
MOLECURE S.A. Stock Molecure S.A.
 59.06M -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 127B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 116B
ARGENX SE Stock argenx SE
 27.69B -
BIONTECH SE Stock BioNTech SE
 19.62B -
GENMAB A/S Stock Genmab A/S
 16.26B
  1. Stock Market
  2. Equities
  3. MOC Stock
  4. Charts Molecure S.A.
  5. Sector Chart